Hannah Peters, Ph.D. is a registered patent agent with experience in drafting and prosecuting U.S. and international patents. She also has experience preparing validity and non-infringement opinions, conducting freedom-to-operate and competitive landscape analyses, and providing litigation support. Drawing on her background in organic chemistry and her research experience in small molecule medicinal chemistry, she works primarily with clients in the life sciences, biotechnology, and pharmaceuticals sectors.
Dr. Peters’ graduate research focused on the design, synthesis and SAR investigation of nucleoside analogs and prodrugs that could be used to develop anticancer and antiviral therapeutics. Her Ph.D. thesis was titled, “The Design, Synthesis, and Biological Evaluation of a Series of Acyclic Fleximer Nucleoside Antivirals.”
Dr. Peters is also a listed inventor on two patents related to fleximer nucleoside analogues. Prior to joining Dechert, Dr. Peters held patent agent positions at a large multinational firm, as well as an IP boutique firm in Washington, D.C.
- Agnes Scott College, B.A., 2009
- University of Maryland, Baltimore County, Ph.D., 2016